PRODUCT INFORMATION
Description
iRGD peptide (Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys) is the archetypal tumor-penetrating peptide. It targets αv integrins and is subsequently cleaved to expose a C-end Rule (CendR) motif, which binds to neuropilin-1 to enhance tissue penetration. It is used in research models to improve the distribution of co-administered agents and exhibits inherent anti-migratory activities in vitro.
Molecular Weight
1064.08
Purity
> 95%
Formula
C₃₇H₆₀F₃N₁₃O₁₆S₂
Product Type
Targeting Peptide
Sequence
Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- P160 Targeting Peptide (CAT#: OLY-1025-YS-21)
- 293P-1 Targeting Peptide (CAT#: OLY-1025-YS-17)
- FFAGLDD TFA Targeting Peptide (CAT#: OLY-1025-YS-49)
- Aminopeptidase N Ligand (CD13) NGR Targeting Peptide (CAT#: OLY-1025-YS-10)
- mUNO Targeting Peptide (CAT#: OLY-1025-YS-29)
- VSLRGDTRG Targeting Peptide (CAT#: OLY-1025-YS-32)
- HN-1 Targeting Peptide (CAT#: OLY-1025-YS-16)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.